Follow the JW생명과학 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, JW생명과학 has logged 15 public disclosures. Market capitalisation: €170.9bn. The latest transaction was filed on 10 July 2026 (Purchase). Among the most active insiders: FILLIMITED. Every trade is accessible without an account.
15
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
n/a
Sell Volume
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 1,654 of 29,068 companies
78.1
score / 100
Value
93
Quality
64
FCF yld15%
Earn yld16%
EV/EBITDA4.4x
ROE14%
Gross mgn28%
Net mgn11%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
JW Life Science is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development of pharmaceutical and biotechnology products.